NASDAQ:ARAY
Accuray Incorporated Stock News
$2.21
+0.0200 (+0.91%)
At Close: Apr 18, 2024
3 Cutting-Edge Healthcare Stocks That Can Pay Off Big Time
07:18pm, Saturday, 18'th Mar 2023
Healthcare costs in America and the world are set to rise in the foreseeable future. All thanks to an aging population, and the expectation that healthcare companies will be able to cure more of our d
Accuray (ARAY) Q2 Earnings and Revenues Top Estimates
06:04pm, Thursday, 02'nd Feb 2023
Despite solid product demand, Accuray (ARAY) reports an overall soft fiscal Q2 performance.
Why Shares of Accuray Jumped Thursday
03:17pm, Thursday, 02'nd Feb 2023
The radiation-oncology machine company saw shares rise after it released an earnings report.
Accuray Achieves Record Product Revenue, But There's Much Work Still To Be Done
01:48pm, Thursday, 02'nd Feb 2023
Accuray's revenue did fall year-over-year as reported, but the company beat expectations and product revenue reached a new all-time high with 8% year-over-year constant-currency growth. Orders grew se
Accuray Incorporated (ARAY) Q2 2023 Earnings Call Transcript
10:59pm, Wednesday, 01'st Feb 2023
Accuray Incorporated (NASDAQ:ARAY ) Q2 2023 Earnings Conference Call February 1, 2023 4:30 PM ET Company Participants Jesse Chew - Senior Vice President, General Counsel & Corporate Secretary Suzanne
Accuray (ARAY) Reports Q2 Loss, Tops Revenue Estimates
07:33pm, Wednesday, 01'st Feb 2023
Accuray (ARAY) delivered earnings and revenue surprises of 33.33% and 7.98%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?
Bear of the Day: Fresenius Medical (FMS)
12:00pm, Friday, 11'th Nov 2022 Zacks Investment Research
Profit estimates are moving in the wrong direction.
Accuray's (ARAY) Q1 Earnings and Revenues Lag Estimates
04:51pm, Thursday, 03'rd Nov 2022 Zacks Investment Research
Despite solid product demand, Accuray (ARAY) reports an overall soft Q1 performance.
Accuray's (ARAY) Q1 Earnings and Revenues Lag Estimates
02:18pm, Thursday, 03'rd Nov 2022
Despite solid product demand, Accuray (ARAY) reports an overall soft Q1 performance.
Accuray (ARAY) Reports Q1 Loss, Misses Revenue Estimates
10:45pm, Wednesday, 02'nd Nov 2022 Zacks Investment Research
Accuray (ARAY) delivered earnings and revenue surprises of -500% and 8.20%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?
Accuray Incorporated (ARAY) Q1 2023 Earnings Call Transcript
09:18pm, Wednesday, 02'nd Nov 2022
Accuray Incorporated (NASDAQ:ARAY ) Q1 2023 Results Conference Call November 2, 2022 4:30 AM ET Company Participants Ken Mobeck - Vice President of Finance and Investor Relations Suzanne Winter - Chie
Accuray (ARAY) Reports Q1 Loss, Misses Revenue Estimates
08:20pm, Wednesday, 02'nd Nov 2022
Accuray (ARAY) delivered earnings and revenue surprises of -500% and 8.20%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?
Stryker's (SYK) Q3 Earnings Miss Estimates, Volume Improves
03:55pm, Tuesday, 01'st Nov 2022 Zacks Investment Research
Stryker's (SYK) third-quarter earnings reflect strong performance across its segments. However, unfavorable currency movement hurt sales growth.
Ecolab (ECL) Q3 Earnings & Revenues Miss Mark, Margins Down
03:53pm, Tuesday, 01'st Nov 2022 Zacks Investment Research
Ecolab's (ECL) robust performance across all its segments drives its Q3 sales, despite business challenges.
DexCom (DXCM) Q3 Earnings Beat Estimates, Guidance Revised
04:58pm, Friday, 28'th Oct 2022 Zacks Investment Research
DexCom's (DXCM) third-quarter results reflect strong domestic and international revenue growth on the back of its real-time Continuous Glucose Monitoring system.
